Selection of initial treatment for bipolar disorder, manic phase

Modern Problems of Pharmacopsychiatry

Volumn 25, Issue , 1997, Pages 88-113

  Frye, Mark A ^a   Altshuler, Lori L ^b,c  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; LITHIUM CARBONATE; TRANQUILIZER;

BIPOLAR DISORDER; CLASSIFICATION; CLINICAL TRIAL; HUMAN; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; REVIEW; TREATMENT FAILURE;

ANTICONVULSANTS; ANTIMANIC AGENTS; BIPOLAR DISORDER; CLINICAL TRIALS; HUMANS; LITHIUM CARBONATE; PSYCHIATRIC STATUS RATING SCALES; TREATMENT FAILURE;

EID: 0030631037     PISSN: 00770094     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000061663     Document Type: Review

References (103)

1. Kraepelin E: Manic-Depressive Insanity and Paranoia. Classics in Psychiatry. Salem, Ayer, 1921.
2. Robins LN, Regier DA: Psychiatric Disorders in America: The Epidemiological Catchment Area Study. New York, MacMillan, 1991.
3. Frye MA, Altshuler LL, Szuba M, Nowlin-Finch N, Mintz J: The relationship between antimanic agent for treatment of classic or dysphoric mania and hospital length of stay. J Clin Psychiatry 1996;57:17-21.
4. Frye MA, Ketter TA, Altshuler LL, Cora-Locatelli G, Denicoff K, Post RM: Clozapine in bipolar manic depression: Treatment implications for other atypical antipsychotics. J Affect Disord, submitted.
5. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1994.
6. Carlson GA, Goodwin FK: The stages of mania: A longitudinal analysis of the manic episode. Arch Gen Psychiatry 1973;28:221-227.
7. Goodwin FK, Jamison KR: Manic-Depressive Illness. New York, Oxford University Press, 1990.
8. Peselow ED, Dunner DL, Fieve RR, Lautin A: Lithium prophylaxis of depression of unipolar, bipolar II, and cyclothymic patients. Am J Psychiatry 1982;139:747-752.
9. Prien RF, Gelenberg AJ: Alternatives to lithium for preventive treatment of bipolar disorder. Am J Psychiatry 1989;146:840-848.
10. Vestergaard P: Treatment and prevention of mania: A Scandinavian perspective. Neuropsychopharmacology 1992;7:249-259.
11. Bowden CL and the Depakote Mania Study Group: Efficacy of divalproex vs. lithium and placebo in the treatment of mania. JAMA 1994;271:918-924.
12. Himmelhoch JM, Garfinkel ME: Mixed mania: Diagnosis and treatment. Psychopharmacol Bull 1986;22:613-620.
13. Dunner DL, Fieve RR: Clinical factors in lithium carbonate prophylaxis failure. Arch Gen Psychiatry 1974;30:229-233.
14. Faedda GL, Baldessarini RJ, Tohen M, Strakowski SM, Waternaux C: Episode sequence in bipolar disorder and response to lithium treatment. Am J Psychiatry 1991;148:1237-1239.
15. O'Connell RA, Mayo JA, Flatow L, Cuthbertson B, O'Brian BE: Outcome of bipolar disorder on long term treatment with lithium. Br J Psychiatry 1991;159:123-129.
16. Levinson DF, Levitt MEM: Schizoaffective mania reconsidered. Am J Psychiatry 1987;144:415-425.
17. Post RM, Uhde TW, Roy-Byrne PP, Joffe RT: Correlates of antimanic response to carbamazepine. Psychiatry Res 1987;21:71-83.
18. Abou-Salek MT, Coppen A: Who responds to prophylactic lithium? J Affect Disord 1986;10:115-125.
19. Prien RF, Himmelhoch JM, Kupfer DJ: Treatment of mixed mania. J Affect Disord 1988;15:9-15.
20. Secunda SK, Katz MM, Swann A, Koslow SH, et al: Mania: Diagnosis, state measurement, and prediction of treatment response. J Affect Disord 1985;8:113-121.
21. Prien RF, Caffe EM, Klett J: Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Arch Gen Psychiatry 1972;26:146-153.
22. Bauer MS, Calabrese J, Dunner DL, Post RM, Whybrow PC, et al: Multisite data reanalysis of the validity of rapid cycling as a course modifier for bipolar disorder in DSM-IV. Am J Psychiatry 1994;151:506-515.
23. Sarantidis D, Waters B: Predictors of lithium prophylaxis effectiveness. Prog Neuropsychopharmacol 1981;5:507-510.
24. Gelenberg AJ, Kane JM, Keller MB, Lavori P, Rosenbaum JF, Cole K, Lavelle J: Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med 1989;321:1489-1493.
25. Post RM, Rubinow DR, Ballenger JC: Conditioning and sensitization in the longitudinal course of affective illness. Br J Psychiatry 1986;149:191.
26. Strakowski SM, McElroy SL, Keck PW, West SA: The co-occurence of mania with medical and other psychiatric disorders. Int J Psychiatry Med 1994;24:305-328.
27. Black DW, Winokur G, Bell S, Nasrallah A, Hulbert J: Complicated mania: Comorbidity and immediate outcome in the treatment of mania. Arch Gen Psychiatry 1988;45:232-236.
28. Regier DA, Farmer ME, Rae D, et al: Comorbidity of mental disorders with alcohol and other drug abuse, results from the epidemiologic catchment area study. JAMA 1989;264:2511-2518.
29. Keller MB, Lavori PW, Coryell W, Andreasen N, et al: Differential outcome of pure manic, mixed/cycling and pure depressive episodes in patients with bipolar illness. JAMA 1986;255:3138-3142.
30. Sonne SC, Brady KT, Morton WA: Substance abuse and bipolar affective disorder. J Nerv Ment Dis 1994;182:349-352.
31. Lenzi A, Lazzerini F, Grossi E, Massimetti G, Placidi GF: Use of carbamazepine in acute psychosis: A case controlled study. J Int Med Res 1986;14:78-84.
32. Lerer B, Moore N, Meyendorff E, Cho SR, Gershon S: Carbamazepine versus lithium in mania: A double blind study. J Clin Psychiatry 1987;48:89-93.
33. Lusznat RM, Murphy DP, Nunn CMH: Carbamazepine vs. lithium in the treatment and prophylaxis of mania. Br J Psychiatry 1988;153:198-204.
34. Okuma T: Effects of carbamazepine and lithium on affective disorders. Neuropsychobiology 1993;27:138-145.
35. Emrich HM: Studies with oxcarbamazepine (Trileptal®) in acute mania. Int Clin Psychopharmacol 1990;5:83-88.
36. Freeman TW, Clothier JL, Pazzaglia PJ, Lesem MD, Swann AC: A double blind comparison of valproate and lithium in the treatment of acute mania. Am J Psychiatry 1992;149:108-111.
37. Cade JFJ: Lithium salts in the treatment of psychotic excitement. Med J Aust 1949;ii:349-352.
38. Arana GW, Hyman SE: Handbook of Psychiatric Drug Therapy, ed 2. Boston, Little, Brown, 1991.
39. Mendlewicz J, Fieve RR, Stallone F: Relationship between the effectiveness of lithium therapy and family history. Am J Psychiatry 1973;130:1011-1013.
40. Dalby MA: Antiepileptic and psychotropic effect of carbamazepine (Tegretol™) in the treatment of psychomotor epilepsy. Epilepsia 1971;12:325-334.
41. Post RM, Ketter TA, Denicoff K, Pazzaglia PJ, Leverich GS, Marangell L, Callahan A, George MS, Frye MA: The place of anticonvulsant therapy in bipolar illness. Psychopharmacology 1996:128;115-129.
42. Albright PS, Burnham WM: Development of a new pharmacological seizure model: Effects of anticonvulsants on cortical and amygdala kindled seizures in the rat. Epilepsia 1980;21:681-689.
43. Ketter TA, Post RM, Denicoff K, Pazzaglia PJ, Marangell LB, George MS, Callahan AM:Carbamazepine in the treatment of mania; in Goodnick PJ (ed): Mania. Washington, American Psychiatric Press, 1994.
44. Denicoff KD, Smith-Jackson E, Disney E, Leverich GS, Post RM: Outcome in bipolar patients randomized to lithium or carbamazepine prophylaxis and crossed over in year two (abstract). 1st Int Conf Bipolar Disord, Pittsburgh, June 23-24, 1994.
45. Altshuler LL, Newman F, Post RM: Lack of epileptiform EEG, activity in refractory affective disorder. Neuropsychiatry Neuropsychol Behav Neurol 1990;3:193-199.
46. Petty F, Rush AJ, Davis JM, Calabrese JR, Small JG, Swann AC, Kramer GL, Orsulak PJ, Blake M, Bowden CL: Plasma GABA predicts response to divalproex in mania. Annu Meet Soc Biol Psychiatry, Miami, May 17-21, 1995.
47. McElroy SL, Keck PE, Pope HG, Hudon JL: Valproate in the treatment of bipolar disorder: Literature review and clinical guidelines. J Clin Psychopharmacol 1992;12:42S-52S.
48. 47a Chapman A, Keane PE, Meldrum BS, Simiand J, Vernieres JC: Mechanism of anticonvulsant action of valproate. Prog Neurobiol 1982;19:315-359.
49. Keck PE Jr, McElroy SL, Tugrul KC, Bennett JA: Valproate oral loading in the treatment of acute mania. J Clin Psychiatry 1993;54:305-308.
50. Calabrese JR, Rapport DJ, Kimmel SE, Reece B, Woyshville MJ: Rapid cycling bipolar disorder and its treatment with valproate. Can J Psychiatry 1993;38:S57-S61.
51. McElroy SL, Keck PE, Pope HG, Hudson JI: Valproate in the treatment of rapid cycling bipolar disorder. J Clin Psychopharmacol 1988;8:275-279.
52. Stoll AL, Banov M, Kolbrener M, Mayer PV, et al: Neurologic factors predict a favorable response in bipolar and schizoaffective disorders. J Clin Psychopharmacol 1994;14:311-313.
53. Chouinard G, Young SN, Annable L: Antimanic effect of clonazepam. Biol Psychiatry 1983;18:451-466.
54. Edwards R, Stephenson U, Flewett T: Clonazepam in acute mania: A double blind trial. Aust NZ J Psychiatry 1991;25:238-242.
55. Bradwejn J, Shriqui C, Koszycki D, Meterissian G: Double blind comparison of the effects of clonazepam and lorazepam in acute mania. J Clin Psychopharmacol 1990;10:403-408.
56. Bottai T, Hue B, Hillaire-Buys D, Barbe A, Pouget R, Petit P: Clonazepam in acute mania: Time-blind evaluation of clinical practice and concentrations in plasma. J Affect Disord 1995;36:21-27.
57. Nowlin-Finch NL, Altshuler LL, Szuba M, Mintz J: Rapid resolution of first episodes of mania: Sleep related? J Clin Psychiatry 1994;55:26-29.
58. Janicak PG, Newman RH, Davis JM: Advances in the treatment of mania and related disorders: A reappraisal. Psychiatr Ann 1992;22:92-103.
59. Tohen M, Zarate CA, Centorrino F, Hegarty J, Froeschl M, Zarate SM: Risperidone in the treatment of mania. J Clin Psychiatry 1996;57:249-253.
60. Singh AN, Catalan J: Risperidone in HIV-related main psychosis. Lancet 1994;344:1029-1030.
61. Goodnick PJ: Risperidone treatment of refractory acute mania. J Clin Psychiatry 1995;56:431-432.
62. Dwight MM, Keck PE Jr, Stanton SP, Strakowski SM, McElroy SL: Antidepressant activity and mania associated with risperidone treatment of schizoaffective disorder (letter). Lancet 1994;344:554-555.
63. Tomlinson WC: Risperidone and mania. Am J Psychiatry 1996;153:132-133.
64. Diaz SF: Mania associated with risperidone use. J Clin Psychiatry 1996;57:41-42.
65. Keck PE, Wilson DR, Strakowski SM, McElroy SL, Kizer DL, Balestreri A: Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders. J Clin Psychiatry 1995;56:466-470.
66. Dubovsky SL: Calcium antagonists in manic-depressive illness. Neuropsychobiology 1993;27:184-192.
67. Mukherjee S, Sackeim HA, Schnurr DB: Electroconvulsive therapy of acute manic episodes: A review. Am J Psychiatry 1994;151:169-176.
68. Small JG, Klapper MH, Kellams JJ, et al: Electroconvulsive treatment compared with lithium in the managment of manic states. Arch Gen Psychiatry 1988;45:727-732.
69. Gjessing R: Disturbances of somatic function in catatonia with periodic course and their compensation. J Ment Sci 1938;84:608-621.
70. Bauer MS, Whybrow PC: Rapid cycling affective disorder II. Treatment of refractory rapid cycling with high dose levothyroxine: A preliminary study. Arch Gen Psychiatry 1990;47:435-440.
71. Baumgartner A, Bauer M, Hellweg R: Treatment of intractable non rapid cycling bipolar affective disorder with high dose thyroxine: An open clinical trial. Neuropsychopharmacology 1994:10:183-189.
72. Whybrow PC: The therapeutic use of triiodothyronine and high dose thyroxine in psychiatric disorder. Acta Med Austriaca 1994;21:44-47.
73. Carroll BT, Gofroth HW, Kennedy J, Dueno OR: Mania due to general medical conditions: Frequency, treatment, and cost. Int J Psychiatry Med, 1996;26:5-13.
74. Carlson GC: Identifying perpubertal mania. J Am Acad Child Adolesc Psychiatry 1995;34:750-753.
75. Strober M, Morrell W, Burroughs, Lampert C, Danforth H, Freeman R: A family study of bipolar I disorder in adolescence: Early onset of symptoms linked to increased familial loading and lithium resistance. J Affect Disord 1988;15:255-268.
76. Hsu LKG: Lithium resistant adolescent mania. J Am Acad Child Psychiatry 1986;25:280-283.
77. Garfinkel ME, Himmelhoch HM, McHugh TR: Lithium carbonate: Treatment for manic or mixed bipolar adolescents. Proc 32nd Annu Meet Am Acad Child Psychiatry, San Antonio, December 1985.
78. Papatheodorou G, Kutcher SP, Katic M, Szalai JP: Efficacy and safety of divalproex sodium in the treatment of acute mania in adolescents and young adults: An open clinical trial. J Clin Psychopharmacol 1995;15:110-116.
79. Althshuler LL, Cohen L, Szuba M, Burt VK, Gitlin M, Mintz J: Pharmacologic management of psychiatric illness in pregnancy: Dilemmas and guidelines. Am J Psychiatry, 1996;153:592-606.
80. Tohen M, Shulman KI, Stalin A: First episode mania in late life. Am J Psychiatry 1994;151:130-132.
81. Jefferson JW: Lithium: A therapeutic wand. J Clin Psychiatry 1989;50:81-86.
82. McFarland BH, Miller M, and Straumfjord: Volproate use in the older manic patient. J Clin Psychiatry 1990;51:479-481.
83. Conlon P: Rapid cycling mood disorder in the elderly. J Geriatr Psychiatry Neurol 1989;2:106-108.
84. Krauthammer C, Klerman GL: Secondary mania; manic syndromes associated with antecedent physical illness of drugs. Arch Gen Psychiatry 1978;30:74-79.
85. Sultzer DL, Cummings JL: Drug induced mania-causative agents, clinical characteristics and management. Med Toxicol Adverse Drug Exper 1989;4:127-143.
86. Kreck PE, McElroy SL, Tugrul K, Bennett JA, Smith JMR: Antiepileptic drugs for the treatment of panic disorder. Neuropsychobiology 1993;27:150-153.
87. Herridge PL, Pope HG: Treatment of bulimia and rapid cycling bipolar disorder with sodium valproate: A case report. J Clin Psychopharmacol 1985;5:229-230.
88. Uhde TW, Stein MB, Post RM: Lack of efficacy of carbamazepine in the treatment of panic disorder. Am J Psychiatry 1988;145:1104-1109.
89. Brady KT, Sonne SC: The relationship between substance abuse and bipolar disorder. J Clin Psychiatry 1995;56(suppl 3):19-24.
90. Post RM, Leverich GS, Altshuler LL, Mikalauskas K: Lithium discontinuation induced refractoriness: Preliminary observations. Am J Psychiatry 1992;149:1727-1729.
91. Pazzaglia PJ, Post RM: Contingent tolerance and re-response to arbamazepine: A case study in a patient with trigeminal neuralgia and bipolar disorder. J Neuropsychiatry Clin Neurosci 1992;4:76-81.
92. Post RM, Ketter TA, Denicoff K, Leverich GS, Mikalauskas K: Assessment of anticonvulsant drugs in bipolar illness; in Hindmarch I, Stones PD (eds): Human Psychopharmacology, vol 4. New York, Wiley, 1993.
93. Secunda SK, Swann A, Katz MM, Koslow SH, Croughan J, Chang S: Diagnosis and treatment of mixed mania. Am J Psychiatry 1987;144:96-98.
94. Murphy DL, Beigel A: Depression, elation, and lithium carbonate responses in manic patient subgroups. Arch Gen Psychiatry 1974;31:643-654.
95. Swann AC, Secunda SK, Katz MM, Koslow SH, Maas J, Chang S, Robins E: Lithium treatment of mania: Clinical characteristics, specificity of symptom change, and outcome. Psychiatry Res 1986;18:127-141.
96. Krishna NR, Taylor MA, Abrams R: Response to lithium carbonate. Biol Psychiatry 1978;13:601-606.
97. Prien RF, Kupfer DJ, Mansky P, et al: Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Arch Gen Psychiatry 1984;41:1096-1104.
98. Mirsa PC, Burns BH: 'Lithium non-responders' in a lithium clinic. Acta Psychiatr Scand 1977;55:32-40.
99. Kukopulos A, Reginaldi D, Laddomada P, et al: Course of the manic-depressive cycle and changes caused by treatments. Pharmacopsychiatry 1980;13:156-167.
100. Haag M, Heidron A, Haag H, Greil W: Response to stabilizing lithium therapy and sequence of affective polarity. Pharmacopsychiatry 1986;19:278-279.
101. Maj M, Pirozzi R, Starace F: Previous pattern of course of the illness as a predictor of response to lithium prophylaxis in bipolar patients. J Affect Disord 1989;17:237-241.
102. Goodnick PJ, Fieve RR, Schlegel A, Baxter N: Predictors of interepisode symptoms and relapse in affective disorder patients treated with lithium carbonate. Am J Psychiatry 1987;144:367-369.
103. Tohen M, Waternaux CM, Tsuang MT, Hunt AT: Four year follow-up of twenty-four first episode manic patients. J Affect Disord 1990;19:79-86.